EI
MDGL icon

Ellevest Inc’s Madrigal Pharmaceuticals MDGL Stock Holding History

Ellevest Inc’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$1.7K – 1110
2023
Q1 		$1.7K Buy
+7
New +$1.91K ﹤0.01% 1476
2022
Q2 		– Sell
-46
Closed -$5K – 1565
2022
Q1 		$5K Hold
46
– – ﹤0.01% 1039
2021
Q4 		$4K Buy
46
+25
+119% +$2.05K ﹤0.01% 1055
2021
Q3 		$2K Sell
21
-12
-36% -$1.04K ﹤0.01% 1150
2021
Q2 		$3K Buy
33
+2
+6% +$237 ﹤0.01% 978
2021
Q1 		$4K Hold
31
– – ﹤0.01% 949
2020
Q4 		$3K Buy
31
+10
+48% +$1.22K ﹤0.01% 916
2020
Q3 		$2K Hold
21
– – ﹤0.01% 913
2020
Q2 		$2K Hold
21
– – ﹤0.01% 896
2020
Q1 		$1K Buy
+21
New +$1.75K ﹤0.01% 926

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return